Brita B. Jensen

1.2k total citations
9 papers, 418 citations indexed

About

Brita B. Jensen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Brita B. Jensen has authored 9 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Brita B. Jensen's work include Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Cancer Treatment and Pharmacology (3 papers). Brita B. Jensen is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Cancer Treatment and Pharmacology (3 papers). Brita B. Jensen collaborates with scholars based in Denmark, Sweden and Greenland. Brita B. Jensen's co-authors include Cai Grau, Elo Andersen, John Jakobsen, Poul Geertsen, Lars Vendelbo Johansen, Benny Vittrup Jensen, Christian Dehlendorff, Niels Henrik Holländer, Mogens K. Boisen and Julia S. Johansen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Brita B. Jensen

8 papers receiving 407 citations

Peers

Brita B. Jensen
Gabriel Calzada United States
Chi‐Chung Tong China
Monica C. Ryoo United States
Collin M.M. Lui China
Alberto Buffoli Italy
Marcus Couey United States
To Wai Leung China
P. Castellucci Italy
Chang-Chuan Pan China
Raven Quinn United States
Gabriel Calzada United States
Brita B. Jensen
Citations per year, relative to Brita B. Jensen Brita B. Jensen (= 1×) peers Gabriel Calzada

Countries citing papers authored by Brita B. Jensen

Since Specialization
Citations

This map shows the geographic impact of Brita B. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brita B. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brita B. Jensen more than expected).

Fields of papers citing papers by Brita B. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brita B. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brita B. Jensen. The network helps show where Brita B. Jensen may publish in the future.

Co-authorship network of co-authors of Brita B. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Brita B. Jensen. A scholar is included among the top collaborators of Brita B. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brita B. Jensen. Brita B. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Brems-Eskildsen, Anne Sofie, A.A. Luczak, Peter Michael Vestlev, et al.. (2015). Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients. Repositorio Institucional E-DocUR (Universidad Del Rosario). 23.
2.
Boisen, Mogens K., Christian Dehlendorff, Dorte Linnemann, et al.. (2014). Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab. PLoS ONE. 9(10). e109430–e109430. 40 indexed citations
3.
Boisen, Mogens K., Julia S. Johansen, Christian Dehlendorff, et al.. (2013). Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer. Annals of Oncology. 24(10). 2554–2559. 76 indexed citations
4.
Boisen, Mogens K., Christian Dehlendorff, Dorte Linnemann, et al.. (2013). Primary tumor location and expression of mir-664 as a combined biomarker for bevacizumab effectiveness in metastatic colorectal cancer.. Journal of Clinical Oncology. 31(15_suppl). 3572–3572. 1 indexed citations
5.
Ejlertsen, Bent, Henning T. Mouridsen, Maj‐Britt Jensen, et al.. (2007). Improved outcome from substituting methotrexate with epirubicin: Results from a randomised comparison of CMF versus CEF in patients with primary breast cancer. European Journal of Cancer. 43(5). 877–884. 51 indexed citations
6.
Lassen, Ulrik, Morten Mau‐Sørensen, Jensen Pb, et al.. (2004). A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results. Journal of Clinical Oncology. 22(14_suppl). 7207–7207. 3 indexed citations
7.
Lassen, Ulrik, Morten Mau‐Sørensen, Jensen Pb, et al.. (2004). A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results. Journal of Clinical Oncology. 22(14_suppl). 7207–7207. 2 indexed citations
8.
Grau, Cai, Lars Vendelbo Johansen, John Jakobsen, et al.. (2000). Cervical lymph node metastases from unknown primary tumours. Radiotherapy and Oncology. 55(2). 121–129. 244 indexed citations
9.
Jensen, Brita B., et al.. (1994). Metastatic or Locally Advanced Colorectal Cancer Treated with 5-Fluorouracil and Low Dose Leucovorin. Acta Oncologica. 33(8). 931–934. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Calzada Breakdown of academic impact, for papers by Chi‐Chung Tong Breakdown of academic impact, for papers by Monica C. Ryoo Breakdown of academic impact, for papers by Collin M.M. Lui Breakdown of academic impact, for papers by Alberto Buffoli Breakdown of academic impact, for papers by Marcus Couey Breakdown of academic impact, for papers by To Wai Leung Breakdown of academic impact, for papers by P. Castellucci Breakdown of academic impact, for papers by Chang-Chuan Pan Breakdown of academic impact, for papers by Raven Quinn
Rankless by CCL
2026